The perseverance of a collaborative team of Dana-Farber scientists led to a new targeted medicine for pediatric low-grade gliomas, now approved by the FDA, that can help children around the world. blog.dana-farber.org/insight/2024/0…

Congratulations to our Dana-Farber colleague Steven Caltrider on being selected as a 2024 In-House Leaders in the Law by Mass. Lawyers Weekly Mass. Lawyers Weekly. dana-farber.org/newsroom/news-…

We are incredibly proud of our Dana-Farber nurse colleagues who were honored at #ONSCongress , and where many presented studies highlighting clinical knowledge, research, patient care & advocacy. dana-farber.org/newsroom/news-…

Congratulations to our colleague Kornelia Polyak, MD, PhD, on being elected as a member of the American Academy of Arts & Sciences (American Academy of Arts & Sciences), recognizing her innovation in basic and translational breast cancer research. dana-farber.org/newsroom/news-…

When Vici Robinson’s breast cancer returned at age 81, she found a program designed for patients like her at Dana-Farber. With her cancer stable, Vici is on the move, doing yoga, and volunteering. blog.dana-farber.org/insight/2024/0…

Congratulations to Dana-Farber's Stuart H. Orkin, MD, who was named one of TIME 100 Most Influential People of 2024. Orkin's research has led to the first gene therapy using #CRISPR to treat sickle cell disease.
Read more ▶️ ms.spr.ly/6011YBwpc

Dana-Farber President and CEO Laurie Glimcher, MD, (Laurie Glimcher MD), and Christopher Lathan, MD, MS, MPH, Chief Clinical Access and Equity Officer, discuss how community hospitals are vital to cancer care in this Boston Herald op-ed.
Read more ➡️ ms.spr.ly/6014YBZj4

Best of luck to all Dana-Farber Marathon Challenge runners today in the #BostonMarathon . We are deeply grateful to all our runners, supporters, and volunteers. Together we are advancing discoveries and treatments for patients with cancer everywhere.

Sending our very best wishes to Dr. Francis Collins as he faces prostate cancer and turns his diagnosis into a teachable moment for all of us and reminds us of the importance of cancer research. washingtonpost.com/health/2024/04…

When Stephanie was diagnosed with rectal cancer, her expert care team at Dana-Farber was ready with a plan. Following treatment with immunotherapy, today the young mom is doing well, and her family is supporting research that can help more patients. blog.dana-farber.org/insight/2024/0…

Congratulations to our Dana-Farber colleague & Nobel laureate Dr. William Kaelin on receiving the highest honor from Fox Chase Cancer Center, the Stanley P. Reimann Honor Award, recognizing his transformative cancer research. foxchase.org/news/2024-04-0…

We are heartbroken by the loss of Larry Lucchino, a pillar of the Dana-Farber community. His strong leadership, advocacy and generosity inspired us and brought hope to so many people affected by cancer. We will be forever grateful for his partnership. He will be greatly missed.

We are incredibly proud and thrilled to earn our fifth consecutive Magnet designation, recognizing nursing excellence and our devotion to the highest quality care for our patients. dana-farber.org/newsroom/news-…

Throughout his 20-year journey with follicular lymphoma, Robert Jenkins formed a bond that grew stronger with his doctor, Eric Jacobsen, MD. With access to the latest therapies and the support of his family, Robert is feeling strong & healthy. blog.dana-farber.org/insight/2024/0…

We are very proud to launch our Neuro-Inclusive Oncology Care and Empowerment Program to support adult oncology patients with intellectual and/or developmental disabilities who often face complex barriers to healthcare. dana-farber.org/newsroom/news-…

Congratulations to our Dana-Farber colleague Dr. Nicoletta Cieri on being awarded NMDP's Amy Strelzer Manasevit Research Program grant, one of the largest in its field, to support her research into allogeneic hematopoietic cell transplantation. dana-farber.org/newsroom/news-…

Our colleague Dr. Sara Tolaney Sara Tolaney spoke with Scientific American Scientific American about the advances in antibody-drug conjugates and their ability to help patients with some of the most challenging cancers. scientificamerican.com/article/a-new-…

We are proud to be among the nation’s leading health care services in providing impactful navigation services to our patients & applaud the administration in working to make them more accessible. The White House whitehouse.gov/ostp/news-upda…

This is such an inspiring story about Chen Wen Ye. Diagnosed with ovarian cancer at 18, she received care from Dana-Farber and is now sharing her experience as a volunteer to help more young patients like her. blog.dana-farber.org/insight/2024/0…

Congratulations to our Dana-Farber colleagues Christopher Fletcher, MD, Timothy Rebbeck, PhD, David Pellman, MD, and Gordon Freeman, PhD on receiving 2024 AACR Scientific Achievement Awards for their innovation that is advancing the science of cancer. dana-farber.org/newsroom/news-…